2372 On Other Exchanges
Symbol
Exchange
2372 is not on other exchanges.

i'rom group co ltd (2372) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for I'ROM GROUP CO LTD (2372)
\

Related News

No related news articles were found.

i'rom group co ltd (2372) Related Businessweek News

No Related Businessweek News Found

i'rom group co ltd (2372) Details

I'rom Group Co., Ltd. provides advanced medicinal treatment, site management organization, contract research organization, and medical support services in Japan. The company supports medical institutions in conducting clinical trials; and provides clinical trial support services for domestic and foreign pharmaceutical companies. It is also involved in the establishment and operation of clinic malls; and technological licensing of regenerative medicine and gene therapy technology. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.

359 Employees
Last Reported Date: 06/28/16
Founded in 1997

i'rom group co ltd (2372) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

i'rom group co ltd
I'rom Group Co., Ltd., 2018 Earnings Call, May 30, 2018

I'rom Group Co., Ltd., 2018 Earnings Call, May 30, 2018

I'rom Group Co., Ltd. to Report Fiscal Year 2018 Results on May 11, 2018

I'rom Group Co., Ltd. announced that they will report fiscal year 2018 results on May 11, 2018

I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2017; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2018

I'rom Group Co., Ltd. reported consolidated earnings results for the nine months ended December 2017. Net sales were JPY 6,191 million compared to JPY 2,972 million a year ago. Operating income was JPY 769 million compared to loss of JPY 241 million a year ago. Ordinary income was JPY 819 million compared to loss of JPY 193 million a year ago. Net income attributable to owners of parent was JPY 1,457 million compared to loss of JPY 212 million a year ago. Diluted net income per share was JPY 125.14. For the fiscal year ending March 2018, on consolidated basis, net sales to be JPY 9,500 million, operating income to be JPY 1,000 million, ordinary income to be JPY 1,100 million, net income attributable to owners of parent to be JPY 1,500 million and net income per share to be JPY 131.45.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2372 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2372.
View Industry Companies
 

Industry Analysis

2372

Industry Average

Valuation 2372 Industry Range
Price/Earnings 16.4x
Price/Sales 2.9x
Price/Book 4.4x
Price/Cash Flow 16.3x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact I'ROM GROUP CO LTD, please visit www.iromgroup.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.